Volume 22, Number 3—March 2016
Dispatch
Patient Diagnostic Rate as Indicator of Tuberculosis Case Detection, South Africa
Table 2
Community | Patient diagnostic rate† |
|
---|---|---|
HIV– (95% CI) | HIV+ (95% CI) | |
A | 0.74 (0.4–1.09) | 1.63 (1.01–2.26) |
B | 0.30 (0.14–0.46) | 4.16 (0.81–7.51) |
C | 0.28 (0.18–0.38) | 1.61 (0.67–2.55) |
D | 0.27 (0.15–0.38) | 0.81 (0.55–1.08) |
E | 0.23 (0.12–0.34) | 1.09 (0.55–1.62) |
F | 0.33 (0.21–0.45) | 2.01 (0.83–3.19) |
G | 0.61 (0.37–0.86) | 2.64 (1.51–3.76) |
H |
0.35 (0.24–0.47) |
1.99 (1.22–2.76) |
Total | 0.34 (0.29–0.39) | 1.53 (1.27–1.79) |
*ZAMSTAR, Zambian South African Tuberculosis and AIDS Reduction trial; HIV–, HIV-negative; HIV+, HIV positive.
†Rate at which prevalent case-patients are recruited by tuberculosis programs, per person-year, calculated by dividing the notification rate by prevalence.
Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.